|
Englishi |
ÖÐÎÄ |
Englishi |
ÖÐÎÄ |
|
adenocarcinoma |
ÏÙ¹ÜÉÏÆ¤£¬ÏÙ°© |
malignant meningioma |
ÄÔĤ£¬¶ñÐÔÄÔĤÁö |
|
adrenal cortical carcinoma |
ÉöÉÏÏÙÆ¤ÖÊ£¬ÉöÉÏÏÙÆ¤Öʰ© |
malignant mesothelioma |
¼äƤ£¬¶ñÐÔ¼äÆ¤Áö |
|
Alpha-Iantitrypsin deficiency |
a-¿¹¼××´ÏÙËØÈ±·¦Ö¢ |
malignant mixed tumor |
ÍÙÒºÏÙ£¬¶ñÐÔ»ìºÏÁö |
|
American Joint Committee on Cancer Staging; AJCC |
ÃÀ¹ú°©Ö¢·ÖÆÚÁªºÏίԱ»á |
malignant pheochromocytoma |
ÉöÉÏÏÙËèÖÊ£¬¶ñÐÔÊȸõϸ°ûÁö |
|
angiosarcoma |
Ѫ¹ÜÄÚÆ¤£¬Ñª¹ÜÈâÁö |
malignant phyllodes tumor |
Èé·¿£¬¶ñÐÔÒ¶×´Áö |
|
basal cell carcinoma |
»ùµ×ϸ°û£¬»ùµ×ϸ°û°© |
malignant teratoma |
¶ñÐÔ»ûÌ¥Áö |
|
breast carcinoma |
ÈéÏÙ°© |
melanoma |
°©Ö¢£¬ºÚËØÁö |
|
carcinoembryonic antigen; CEA |
°©Åß¿¹Ô |
mesothelioma |
¼äƤÁö |
|
carcinoma |
¶ñÐÔÉÏÆ¤Ö×Áö |
Microinvasive carcinoma |
΢ÇÖÏ®°© |
|
Carcinoma in situ |
Ôλ°© |
mild dysplasia |
Çá¶ÈÒìÉú |
|
catecholamine |
¶ù²è·Ó°· |
moderate dysplasia |
ÖжÈÒìÉú |
|
cerebroma |
ÄÔÁö |
moderately differentiated |
Öжȷֻ¯ |
|
chondrosarcoma |
Èí¹Ç£¬Èí¹ÇÈâÁö |
multiple myeIoma |
¶à·¢ÐÔ¹ÇËèÁö |
|
choriocarcinoma |
Ì¥ÅÌÉÏÆ¤£¬ÈÞëĤ°© |
myeloma |
½¬Ï¸°û£¬¹ÇËèÁö |
|
colon cancer |
½á³¦°© |
neuroblastoma |
Éñ¾½Úϸ°û£¬Éñ¾Ä¸Ï¸°ûÁö |
|
Cysticfibrosis |
ÄÒÐÔÏËά±äÐÔ |
neuroblastoma |
Éñ¾Ä¸Ï¸°ûÁö |
|
direct extension |
Ö±½ÓÂûÑÓ |
neuroblastoma |
Éñ¾Ä¸Ï¸°ûÁö |
|
dysgerminoma |
¶ñÐÔÅßÌ¥Áö |
neuron-specific enolase; NSE |
Éñ¾ÌØÒìÐÔÏ©´¼ |
|
Dysplasia |
񓃜 |
oma |
Á¼ÐÔÖ×Áö |
|
Familialhypercholesterolemia |
¼Ò×åÐÔµ¨¹Ì´¼¹ý¶àÖ¢ |
osteosarcoma |
Ó²¹Ç£¬¹ÇÈâÁö |
|
Fanconi sanemia Fanconi's |
ƶѪ֢ |
ova-rian |
Âѳ²°© |
|
fibrosarcoma |
ÏËά×éÖ¯£¬ÏËάÈâÁö |
poorly differentiated |
·Ö»¯²»Á¼ |
|
glioma |
Éñ¾½ºÏ¸°û£¬Éñ¾½ºÏ¸°ûÁö |
prostate-specific antigen; PSA |
ǰÁÐÏÙÌØÒìÐÔ¿¹Ô |
|
hematogenous metastasis |
ѪÐÐ×ªÒÆ |
prostatic acid phosphatase; PAP |
ǰÁÐÏÙËáÐÔÁ×Ëá |
|
HemophiIia |
ѪÓѲ¡ |
prostatic csarcinoma |
ǰÁÐÏÙ°© |
|
hepatocellular carcinoma; hepatoma |
¸Îϸ°û£¬¸Îϸ°û°© |
Purine nucleoside phosphorylase deficiency |
æÎÒ÷ºË¿àËáÁ×ËáËáȱ·¦Ö¢ |
|
hepatoma ;liver cancer |
¸Î°© |
renal cell carcinoma |
ÉöÔàÉÏÆ¤£¬Éöϸ°û°© |
|
histopathological grading |
×éÖ¯²¡Àí·Ö»¯ |
renaleelI |
Éöϸ°û°© |
|
human chorionic gonadotropin; HCG |
ÈËÀàÈÞëĤ´ÙÐÔÏÙËØ |
rhabdomyosarcoma |
ºáÎÆ¼¡£¬ºáÎÆ¼¡ÈâÁö |
|
Hunter'ssyndrome |
ºàÌØÊÏ×ÛºÏÖ¢ |
sarcoma |
¶ñÐÔ¼äÒ¶Ö×Áö |
|
immature teratoma |
È«ÄÜϸ°û£¬Î´³ÉÊì»ûÌ¥Áö |
SCID |
ÑÏÖØ¸´ºÏÃâÒßȱʧ֢ |
|
Invasive carcinoma |
ÇÖÏ®°© |
seminoma |
Éúֳϸ°û£¬¾«Ï¸°ûÁö |
|
leiomyosarcoma |
ƽ»¬¼¡£¬Æ½»¬¼¡ÈâÁö |
severe dysplasia |
ÖØ¶ÈÒìÉú |
|
leukemia |
ÔìѪϸ°û£¬°×Ѫ²¡ |
squamous cell carcinoma |
ÁÛ×´ÉÏÆ¤£¬ÁÛ״ϸ°û°© |
|
leukemia |
×Ôϸ°ûÁö |
stage |
ÆÚ±ð |
|
liposarcoma |
Ö¬·¾×éÖ¯£¬Ö¬·¾ÈâÁö |
synovial sarcoma |
»¬Ä¤£¬»¬Ä¤ÈâÁö |
|
lung cancer |
·Î°© |
thymic carcinoma |
ÐØÏÙÉÏÆ¤£¬ÐØÏÙ°© |
|
lymphangiosarcoma |
Áܰ͹ÜÄÚÆ¤£¬Áܰ͹ÜÈâÁö |
transitional cell carcinoma |
ÃÚÄòµÀÉÏÆ¤£¬¹ý¶Éϸ°û°© |
|
lymphatic metastasis |
ÁܰÍ×ªÒÆ |
tumor marker |
ÁÙ´²¼ìÑ飬º¬Ö×Áö±ê¼Ç |
|
lymphoma |
ÀàÁܰÍ×éÖ¯£¬ÁܰÍÁö |
undifferentiated |
δ·Ö»¯ |
|
lymphoma |
ÁܰÍÈâÁö |
well differentiated |
·Ö»¯Á¼ºÃ |
|
malignant melanoma |
Éñ¾ÍâÅ߲㣬¶ñÐÔºÚÉ«ËØÁö |
¼Ò×åÐÔÆ¢ÐÔÆ¶Ñª |
Gaucher's²¡ |